Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Zhaoke Ophthalmology's TAB014 Receives BLA Review for wAMD Treatment
CompanyDrug

Zhaoke Ophthalmology’s TAB014 Receives BLA Review for wAMD Treatment

June 13, 2025
GSK Licenses Shigella Vaccine to Bharat Biotech for Low- and Middle-Income Countries
CompanyDeals

GSK Licenses Shigella Vaccine to Bharat Biotech for Low- and Middle-Income Countries

June 13, 2025
MSD Launches Phase III Trial for Quadrivalent Dengue Vaccine V181
CompanyDrug

Merck Launches Phase III Trial for Quadrivalent Dengue Vaccine V181

June 13, 2025
NVIDIA and Novo Nordisk Collaborate to Accelerate AI-Driven Drug Discovery
CompanyDeals

NVIDIA and Novo Nordisk Collaborate to Accelerate AI-Driven Drug Discovery

June 13, 2025
Sanofi's Rilzabrutinib Shows Promise in IgG4-Related Disease Trial
CompanyDrug

Sanofi’s Rilzabrutinib Shows Promise in IgG4-Related Disease Trial

June 13, 2025
Bayer Extends Genomics Partnership With Broad Institute for Cardiology Research
CompanyDeals

Bayer Extends Genomics Partnership With Broad Institute for Cardiology Research

June 13, 2025
Bayzed Health Launches HK IPO to Expand Cancer Care Services
CompanyDeals

Bayzed Health Launches HK IPO to Expand Cancer Care Services

June 13, 2025
TransThera Sciences Sets Hong Kong IPO at HKD13.15 Per Share
CompanyDeals

TransThera Sciences Sets Hong Kong IPO at HKD13.15 Per Share

June 13, 2025
BeOne Medicines Wins FDA Approval for Brukinsa Tablet Across All Five Indications
CompanyDrug

BeOne Medicines Wins FDA Approval for Brukinsa Tablet Across All Five Indications

June 13, 2025
Gene Solutions Partners with Topgen Biopharm to Advance Precision Oncology in Asia
CompanyDeals

Gene Solutions Partners with Topgen Biopharm to Advance Precision Oncology in Asia

June 13, 2025
Suzhou's MEI Medical Secures RMB 100M Funding for ePTFE Innovation
CompanyDeals

Suzhou’s MEI Medical Secures RMB 100M Funding for ePTFE Innovation

June 13, 2025
BMS Reports Positive POETYK PsA-1 Results for Sotyktu in Psoriatic Arthritis
CompanyDrug

BMS Reports Positive POETYK PsA-1 Results for Sotyktu in Psoriatic Arthritis

June 13, 2025
1 2 … 15 16 17 18 19 … 27 28
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up